WHO Drug Information Vol. 20, No. 4, 2006 - World Health ...

More documents

Recommendations

Info

WHO Drug Information, Vol. 20, No. 4, 2006 Proposed INN: List 96 C31H43N3O8 H 2C O N H O NH CH 3 H H 3CO H3C O HO H H H H CH3 OCH3 CH3 75747-14-7 O NH 2 telatinibum telatinib 4-[({4-[(4-chlorophenyl)amino]furo[2,3-d]pyridazin-7-yl}oxy)methyl]- N-methylpyridine-2-carboxamide antineoplastic télatinib 4-[({4-[(4-chlorophényl)amino]furo[2,3-d]pyridazin-7-yl}oxy)méthyl]- N-méthylpyridine-2-carboxamide antinéoplasique telatinib 4-[({4-[(4-clorofenil)amino]furo[2,3-d]piridazin-7-il}oxi)metil]- N-metilpiridina-2-carboxamida antineoplásico C20H16ClN5O3 H 3C N H O N O O N N tesamorelinum tesamorelin (3E)-hex-3-enoylsomatoliberin (human GHRH) growth hormone release-stimulating peptides H N H O 332012-40-5 tésamoréline (3E)-hex-3-enoylsomatolibérine humaine peptide stimulant la libération de l'hormone de croissance tesamorelina (3E)-hex-3-enoilsomatoliberina humana péptido estimulante de la liberación de la hormona del crecimiento C221H366N72O67S O H 3C Cl 218949-48-5 Tyr Ala Asp Ala Ile Phe Thr Asn Ser Tyr 10 Arg Lys Val Leu Gly Gln Leu Ser Ala Arg 20 Lys Leu Leu Gln Asp Ile Met Ser Arg Gln 30 Gln Gly Glu Ser Asn Gln Glu Arg Gly Ala 40 Arg Ala Arg Leu NH2 297
Proposed INN: List 96 WHO Drug Information, Vol. 20, No. 4, 2006 vernakalantum vernakalant (3R)-1-{(1R,2R)-2-[2-(3,4-dimethoxyphenyl)ethoxy]cyclohexyl}= pyrrolidin-3-ol antiarrhythmic 298 vernakalant (3R)-1-{(1R,2R)-2-[2-(3,4-diméthoxyphényl)éthoxy]cyclohexyl}= pyrrolidin-3-ol antiarythmique vernakalant (3R)-1-{(1R,2R)-2-[2-(3,4-dimetoxifenil)etoxi]ciclohexil}pirrolidin-3-ol antiarrítmico C20H31NO4 H 3CO H 3CO O H H N OH H 794466-70-9 votucalisum votucalis methionyl[145-leucine]FS-HBP2 (Rhipicephalus appendiculatus (Brown ear tick) Female-Specific Histamine-Bending Protein 2) histamine binding protein votucalis méthionyl[145-leucine]FS-HBP2 (Protéine 2 se liant à l’histamine spécifique à la tique femelle Rhipicephalus appendiculatus) protéine se liant à l'histamine votucalis metionil[145-leucina]FS-HBP2 (Proteína 2 que se une a la histamina específica de la garrapata hembra Rhipicephalus appendiculatus) proteína captora de histamina C858H1259N221O289S10 872525-61-6 NQPDWADEAA NGAHQDAWKS LKADVENVYY MVKATYKNDP M VWGNDFTCVG 50 VMANDVNEDE KSIQAEFLFM NNADTNMQFA TEKVTAVKMY GYNRENAFRY 100 ETEDGQVFTD VIAYSDDNCD VIYVPGTDGN EEGYELWTTD YDNILANCLN 150 KFNEYAVGRE TRDVFTSACL E 171 Disulfide bridges location / Position des ponts disulfure / Posiciones de los puentes disulfuro 48-169 119-148
Page 1 and 2:
WHO DRUG INFORMATION V O L U M E 20
Page 3 and 4:
World Health Organization 238 Annou
Page 5 and 6:
Medicines for Tuberculosis • Acce
Page 7 and 8:
Medicines for Tuberculosis pounds c
Page 9 and 10:
Medicines for Tuberculosis InhA Inh
Page 11 and 12: 246 WHO Drug Information Vol 20, No
Page 13 and 14: Safety and Efficacy Issues 5. CDC.
Page 15 and 16: Safety and Efficacy Issues Referenc
Page 17 and 18: Safety and Efficacy Issues ADRAC ad
Page 19 and 20: Safety and Efficacy Issues 2. Clari
Page 21 and 22: Safety and Efficacy Issues Leflunom
Page 23 and 24: Safety and Efficacy Issues contribu
Page 25 and 26: Safety and Efficacy Issues Tigecycl
Page 27 and 28: Rational Use of Medicines The study
Page 29 and 30: Rational Use of Medicines fluticaso
Page 31 and 32: Topics of Current Interest Plan for
Page 33 and 34: Topics of Current Interest In order
Page 35 and 36: Topics of Current Interest from the
Page 37 and 38: Regulatory Action and News after se
Page 39 and 40: Regulatory Action and News The chan
Page 41 and 42: Recent Publications, Information an
Page 47 and 48: Proposed INN: List 96 WHO Drug Info
Page 61: Proposed INN: List 96 WHO Drug Info
Page 79: Proposed INN: List 96 WHO Drug Info
show all

WHO Drug Information Vol. 20, No. 4, 2006 - World Health ...

Create successful ePaper yourself

Delete template?

Save as template?